The test, which leverages technology that mimics a dog's ability to sense disease in humans, analyzes cancer-associated volatile organic compounds found in urine samples.
NEW YORK – Roche on Monday announced that it has received CE marking for a blood test to detect neuroinflammation in patients with multiple sclerosis. The Elecsys Neurofilament Light Chain test ...
The parties will work on tests in areas including cancer, genetics, immune disorders, and rare diseases and streamline the path from discovery to national availability.
The assay measures three host-immune proteins to indicate the likelihood of bacterial or viral infections, and is validated for use on Beckman Coulter immunoassay analyzers.
NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...
With the deal, Austin, Texas-based Function adds to its clinical lab offerings, allowing its members to schedule at-home or in-office blood draws.
MedStar Health will deploy PathAI's AISight for the more than 40 pathologists at its multi-site health system serving the Washington, D.C. area.
The collaboration aims to develop a blood-based test that measures naturally occurring antibodies against toxic amyloid‑β oligomers in healthy individuals.
The study aims to collect data on the performance of blood-based and digital biomarkers to assess their ability to diagnose or predict pathologies associated with Alzheimer's.
Last week, readers were most interested in a story about Baebies' multifunctional POC system that offers molecular testing alongside another test modality.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results